Biomea Fusion Presents Phase II COVALENT-111 Data in Type 2 Diabetes at the 19th International Conference on Advanced Technologies & Treatments for Diabetes 2026
SAN CARLOS, Calif., March 14, 2026 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc.…
Biomea Fusion to Participate in Citi’s SMID Biotech C-Suite Fireside Chat Series
October 21, 2025 19:05 ET | Source: Biomea Fusion, Inc. SAN CARLOS,…


